Genfit (GNFT.PA) announced the appointment of Pejvack Motlagh as Chief Medical Officer.
Motlag has more 20 years of experience in the pharmaceutical and biotechnology industry. Prior to joining GENFIT, He served as CMO at Egle Therapeutics. He also held the role of CMO at Mablink Biosciences. Earlier in his career, Motlagh contributed to the success of several large pharmaceutical organizations.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.